[Rheumatoid polyarthritis: etiology, diagnosis, course, treatment principles].
de Bandt
M
M
Service de rhumatologie, groupe hospitalier Bichat-Claude-Bernard, Paris.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000700:Analgesics / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000628:therapy; D015415:Biomarkers; D016207:Cytokines / Q000037:antagonists & inhibitors; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D008875:Middle Aged; D050607:Organogold Compounds; D011379:Prognosis; D011859:Radiography; D012460:Sulfasalazine / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000700:Analgesics; D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D015415:Biomarkers; D016207:Cytokines; D007166:Immunosuppressive Agents; D050607:Organogold Compounds; D012460:Sulfasalazine; D006886:Hydroxychloroquine; D008727:Methotrexate